English

Aqua Bio Technology ASA

ESEF

Report (type unavailable) · filed 2026-10-21

Annual consolidated revenue for 2025: about NOK 1.339M, using the latest reported figures. The previous period, 2024, was about NOK 10.5M.

Inspect reported changes Compare with another company Historical disclosures Segments

Watchlist

Latest fiscal year

Revenue

1.34 million NOK

2025 · NOK

Exact inputs and evidence

Revenue: 1338883 NOK Source

Operating margin

-871.41%

2025 · %

Exact inputs and evidence

Operating Income: -11667180 NOK Source
Revenue: 1338883 NOK Source

Operating cash flow

-8.15 million NOK

2025 · NOK

Exact inputs and evidence

Operating Cash Flow: -8152556 NOK Source

Free cash flow

-8.15 million NOK

2025 · NOK

Exact inputs and evidence

Operating Cash Flow: -8152556 NOK Source
Capital Expenditure Including Intangibles: 0 NOK Source

Cash and cash equivalents: 2.66 million NOK 2025-12-31 Source
Exact value

2658175 NOK
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-21.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2025-12-31
Operating income: 6 of 11 periods available· newest 2025-12-31
net income: No compatible figures in this window
Operating cash flow: 6 of 11 periods available· newest 2025-12-31
capital expenditure: No compatible figures in this window
Total assets: 6 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 6 of 11 periods available· newest 2025-12-31
Current liabilities: 6 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-87.2%

Prior period

NOK 10.5 million

2024-01-01 – 2024-12-31
Current period

NOK 1.34 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

1338883 − 10496791 = -9157908 NOK

10496791 NOK · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1338883 NOK · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Aqua Bio Technology ASA · 2025-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Year-over-year change in Revenue: -9157908 NOK Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1338883 NOK (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2025-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2025-12-31.zip#1695558 Filing: 529900RG33DF0N88RJ88-2025-12-31-ESEF-NO-0 Input fundies:Revenue: 10496791 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2025-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2025-12-31.zip#1696049 Filing: 529900RG33DF0N88RJ88-2025-12-31-ESEF-NO-0
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+NOK 48.05 million

Prior period

−NOK 56.21 million

2024-01-01 – 2024-12-31
Current period

−NOK 8.15 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-8152556 − -56205695 = 48053139 NOK

-56205695 NOK · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-8152556 NOK · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Aqua Bio Technology ASA · 2025-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Year-over-year change in Operating cash flow: 48053139 NOK Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -8152556 NOK (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2025-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2025-12-31.zip#1912911 Filing: 529900RG33DF0N88RJ88-2025-12-31-ESEF-NO-0 Input fundies:OperatingCashFlow: -56205695 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2025-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2025-12-31.zip#1913444 Filing: 529900RG33DF0N88RJ88-2025-12-31-ESEF-NO-0
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue NOK 1.34 million 100% of revenue
Operating costs Derived NOK 13.01 million 971% of revenue
Operating income −NOK 11.67 million −871% of revenue
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow −NOK 8.15 million −609% of revenue
Capital expenditure including intangibles NOK 0 0% of revenue
Free cash flow Derived Capital expenditure here includes intangible assets. −NOK 8.15 million −609% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Not shown: operating income or net income is not reported.
2021 Not shown: operating income or net income is not reported.
2022 Not shown: operating income or net income is not reported.
2023 Not shown: operating income or net income is not reported.
2024 Not shown: operating income or net income is not reported.
2025 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	444376	16549097 Derived	-16104721	Unavailable	Unavailable	-13470695 Derived Capital expenditure here includes intangible assets.	Source 2020-01-01 – 2020-12-31: 444376 NOK Inspect Revenue Open source 2020-01-01 – 2020-12-31: -16104721 NOK Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -13335007 NOK Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 135688 NOK Inspect Capital Expenditure Including Intangibles Open source
2021 2021-01-01 – 2021-12-31	1559703	19416848 Derived	-17857145	Unavailable	Unavailable	-20969382 Derived Capital expenditure here includes intangible assets.	Source 2021-01-01 – 2021-12-31: 1559703 NOK Inspect Revenue Open source 2021-01-01 – 2021-12-31: -17857145 NOK Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -20969382 NOK Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 0 NOK Inspect Capital Expenditure Including Intangibles Open source
2022 2022-01-01 – 2022-12-31	7016752	23384648 Derived	-16367896	Unavailable	Unavailable	-15448936 Derived Capital expenditure here includes intangible assets.	Source 2022-01-01 – 2022-12-31: 7016752 NOK Inspect Revenue Open source 2022-01-01 – 2022-12-31: -16367896 NOK Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -15448936 NOK Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 0 NOK Inspect Capital Expenditure Including Intangibles Open source
2023 2023-01-01 – 2023-12-31	18405719	34190511 Derived	-15784792	Unavailable	Unavailable	-19342617 Derived Capital expenditure here includes intangible assets.	Source 2023-01-01 – 2023-12-31: 18405719 NOK Inspect Revenue Open source 2023-01-01 – 2023-12-31: -15784792 NOK Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -19274417 NOK Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 68200 NOK Inspect Capital Expenditure Including Intangibles Open source
2024 2024-01-01 – 2024-12-31	10496791	96235780 Derived	-85738989	Unavailable	Unavailable	-57271371 Derived Capital expenditure here includes intangible assets.	Source 2024-01-01 – 2024-12-31: 10496791 NOK Inspect Revenue Open source 2024-01-01 – 2024-12-31: -85738989 NOK Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -56205695 NOK Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 1065676 NOK Inspect Capital Expenditure Including Intangibles Open source
2025 2025-01-01 – 2025-12-31	1338883	13006063 Derived	-11667180	Unavailable	Unavailable	-8152556 Derived Capital expenditure here includes intangible assets.	Source 2025-01-01 – 2025-12-31: 1338883 NOK Inspect Revenue Open source 2025-01-01 – 2025-12-31: -11667180 NOK Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -8152556 NOK Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 0 NOK Inspect Capital Expenditure Including Intangibles Open source

Amounts are exact, in NOK.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

NOK 1.3M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(NOK)	Source evidence
20202020-12-31	Revenue	444376	Revenue: 444376 Open source
20212021-12-31	Revenue	1559703	Revenue: 1559703 Open source
20222022-12-31	Revenue	7016752	Revenue: 7016752 Open source
20232023-12-31	Revenue	18405719	Revenue: 18405719 Open source
20242024-12-31	Revenue	10496791	Revenue: 10496791 Open source
20252025-12-31	Revenue	1338883	Revenue: 1338883 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-87.2% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 444376 Open source
20212021-12-31	Year over year	251%	Revenue: 1559703 Open source Revenue: 444376 Open source
20222022-12-31	Year over year	349.9%	Revenue: 7016752 Open source Revenue: 1559703 Open source
20232023-12-31	Year over year	162.3%	Revenue: 18405719 Open source Revenue: 7016752 Open source
20242024-12-31	Year over year	-43%	Revenue: 10496791 Open source Revenue: 18405719 Open source
20252025-12-31	Year over year	-87.2%	Revenue: 1338883 Open source Revenue: 10496791 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -871.4% 2025

Free cash flow margin -608.9% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	-3,624.1%	Operating Income: -16104721 Open source Revenue: 444376 Open source
20212021-12-31	Operating margin	-1,144.9%	Operating Income: -17857145 Open source Revenue: 1559703 Open source
20222022-12-31	Operating margin	-233.3%	Operating Income: -16367896 Open source Revenue: 7016752 Open source
20232023-12-31	Operating margin	-85.8%	Operating Income: -15784792 Open source Revenue: 18405719 Open source
20242024-12-31	Operating margin	-816.8%	Operating Income: -85738989 Open source Revenue: 10496791 Open source
20252025-12-31	Operating margin	-871.4%	Operating Income: -11667180 Open source Revenue: 1338883 Open source
2020-12-31	Net margin	Not reported	Revenue: 444376 Open source
2021-12-31	Net margin	Not reported	Revenue: 1559703 Open source
2022-12-31	Net margin	Not reported	Revenue: 7016752 Open source
2023-12-31	Net margin	Not reported	Revenue: 18405719 Open source
2024-12-31	Net margin	Not reported	Revenue: 10496791 Open source
2025-12-31	Net margin	Not reported	Revenue: 1338883 Open source
20202020-12-31	Free cash flow margin	-3,031.4%	Revenue: 444376 Open source Operating Cash Flow: -13335007 Open source Capital Expenditure Including Intangibles: 135688 Open source
20212021-12-31	Free cash flow margin	-1,344.4%	Revenue: 1559703 Open source Operating Cash Flow: -20969382 Open source Capital Expenditure Including Intangibles: 0 Open source
20222022-12-31	Free cash flow margin	-220.2%	Revenue: 7016752 Open source Operating Cash Flow: -15448936 Open source Capital Expenditure Including Intangibles: 0 Open source
20232023-12-31	Free cash flow margin	-105.1%	Revenue: 18405719 Open source Operating Cash Flow: -19274417 Open source Capital Expenditure Including Intangibles: 68200 Open source
20242024-12-31	Free cash flow margin	-545.6%	Revenue: 10496791 Open source Operating Cash Flow: -56205695 Open source Capital Expenditure Including Intangibles: 1065676 Open source
20252025-12-31	Free cash flow margin	-608.9%	Revenue: 1338883 Open source Operating Cash Flow: -8152556 Open source Capital Expenditure Including Intangibles: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

NOK -8.2M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(NOK)	Source evidence
20202020-12-31	Operating cash flow	-13335007	Operating Cash Flow: -13335007 Open source
20212021-12-31	Operating cash flow	-20969382	Operating Cash Flow: -20969382 Open source
20222022-12-31	Operating cash flow	-15448936	Operating Cash Flow: -15448936 Open source
20232023-12-31	Operating cash flow	-19274417	Operating Cash Flow: -19274417 Open source
20242024-12-31	Operating cash flow	-56205695	Operating Cash Flow: -56205695 Open source
20252025-12-31	Operating cash flow	-8152556	Operating Cash Flow: -8152556 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

NOK -8.2M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(NOK)	Source evidence
20202020-12-31	Free cash flow	-13470695	Operating Cash Flow: -13335007 Open source Capital Expenditure Including Intangibles: 135688 Open source
20212021-12-31	Free cash flow	-20969382	Operating Cash Flow: -20969382 Open source Capital Expenditure Including Intangibles: 0 Open source
20222022-12-31	Free cash flow	-15448936	Operating Cash Flow: -15448936 Open source Capital Expenditure Including Intangibles: 0 Open source
20232023-12-31	Free cash flow	-19342617	Operating Cash Flow: -19274417 Open source Capital Expenditure Including Intangibles: 68200 Open source
20242024-12-31	Free cash flow	-57271371	Operating Cash Flow: -56205695 Open source Capital Expenditure Including Intangibles: 1065676 Open source
20252025-12-31	Free cash flow	-8152556	Operating Cash Flow: -8152556 Open source Capital Expenditure Including Intangibles: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

100.4% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	48.8%	Total Liabilities: 7916849 Open source Total Assets: 16237927 Open source
20212021-12-31	Liabilities / assets	45.7%	Total Liabilities: 15723080 Open source Total Assets: 34429500 Open source
20222022-12-31	Liabilities / assets	97.2%	Total Liabilities: 65342195 Open source Total Assets: 67202711 Open source
20232023-12-31	Liabilities / assets	63.9%	Total Liabilities: 151968839 Open source Total Assets: 237744289 Open source
20242024-12-31	Liabilities / assets	161.4%	Total Liabilities: 283172312 Open source Total Assets: 175404976 Open source
20252025-12-31	Liabilities / assets	100.4%	Total Liabilities: 130508348 Open source Total Assets: 130019276 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.03× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	1.94×	Current Assets: 6444253 Open source Current Liabilities: 3325972 Open source
20212021-12-31	Current assets / current liabilities	1.81×	Current Assets: 21858333 Open source Current Liabilities: 12057642 Open source
20222022-12-31	Current assets / current liabilities	0.51×	Current Assets: 12769421 Open source Current Liabilities: 24823348 Open source
20232023-12-31	Current assets / current liabilities	0.41×	Current Assets: 48840679 Open source Current Liabilities: 119508148 Open source
20242024-12-31	Current assets / current liabilities	0.1×	Current Assets: 19223083 Open source Current Liabilities: 193252986 Open source
20252025-12-31	Current assets / current liabilities	0.03×	Current Assets: 3280637 Open source Current Liabilities: 129561660 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	Unavailable Not reported for this period.	−NOK 13.34 million Exact value Exact value: -13335007 NOK 2020-01-01 – 2020-12-31: -13335007 NOK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aqua Bio Technology ASA · 2020-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Operating Cash Flow: -13335007 NOK Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=NOK&dimensions= Input fundies:OperatingCashFlow: -13335007 NOK (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2021-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2021-12-31-no.zip#12866584 Filing: 529900RG33DF0N88RJ88-2021-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	NOK 135,688 Capital expenditure here includes intangible assets. Exact value Exact value: 135688 NOK 2020-01-01 – 2020-12-31: 135688 NOK Inspect Capital Expenditure Including Intangibles Open source Share or cite Citation for Capital Expenditure Including Intangibles · Aqua Bio Technology ASA · 2020-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Capital Expenditure Including Intangibles: 135688 NOK Concept: fundies:CapitalExpenditureIncludingIntangibles Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88/explain?concept=fundies%3ACapitalExpenditureIncludingIntangibles&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=NOK&dimensions= Input fundies:CapitalExpenditureIncludingIntangibles: 135688 NOK (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2021-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2021-12-31-no.zip#12868524 Filing: 529900RG33DF0N88RJ88-2021-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−NOK 13.47 million Capital expenditure here includes intangible assets. Calculation and evidence -13335007 − 135688 NOK Exact free cash flow: -13470695 NOK 2020-01-01 – 2020-12-31: -13335007 NOK · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 135688 NOK · Inspect Capital Expenditure Including Intangibles · Source Share or cite Citation for Free cash flow · Aqua Bio Technology ASA · 2020-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Free cash flow: -13470695 NOK Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13335007 NOK (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2021-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2021-12-31-no.zip#12866584 Filing: 529900RG33DF0N88RJ88-2021-12-31-ESEF-NO-0 Input fundies:CapitalExpenditureIncludingIntangibles: 135688 NOK (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2021-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2021-12-31-no.zip#12868524 Filing: 529900RG33DF0N88RJ88-2021-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	Unavailable Not reported for this period.	−NOK 20.97 million Exact value Exact value: -20969382 NOK 2021-01-01 – 2021-12-31: -20969382 NOK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aqua Bio Technology ASA · 2021-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Operating Cash Flow: -20969382 NOK Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=NOK&dimensions= Input fundies:OperatingCashFlow: -20969382 NOK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2022-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2022-12-31-no.zip#12533427 Filing: 529900RG33DF0N88RJ88-2022-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	NOK 0 Capital expenditure here includes intangible assets. Exact value Exact value: 0 NOK 2021-01-01 – 2021-12-31: 0 NOK Inspect Capital Expenditure Including Intangibles Open source Share or cite Citation for Capital Expenditure Including Intangibles · Aqua Bio Technology ASA · 2021-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Capital Expenditure Including Intangibles: 0 NOK Concept: fundies:CapitalExpenditureIncludingIntangibles Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88/explain?concept=fundies%3ACapitalExpenditureIncludingIntangibles&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=NOK&dimensions= Input fundies:CapitalExpenditureIncludingIntangibles: 0 NOK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2022-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2022-12-31-no.zip#12535303 Filing: 529900RG33DF0N88RJ88-2022-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−NOK 20.97 million Capital expenditure here includes intangible assets. Calculation and evidence -20969382 − 0 NOK Exact free cash flow: -20969382 NOK 2021-01-01 – 2021-12-31: -20969382 NOK · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 0 NOK · Inspect Capital Expenditure Including Intangibles · Source Share or cite Citation for Free cash flow · Aqua Bio Technology ASA · 2021-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Free cash flow: -20969382 NOK Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20969382 NOK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2022-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2022-12-31-no.zip#12533427 Filing: 529900RG33DF0N88RJ88-2022-12-31-ESEF-NO-0 Input fundies:CapitalExpenditureIncludingIntangibles: 0 NOK (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2022-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2022-12-31-no.zip#12535303 Filing: 529900RG33DF0N88RJ88-2022-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	Unavailable Not reported for this period.	−NOK 15.45 million Exact value Exact value: -15448936 NOK 2022-01-01 – 2022-12-31: -15448936 NOK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aqua Bio Technology ASA · 2022-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Operating Cash Flow: -15448936 NOK Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=NOK&dimensions= Input fundies:OperatingCashFlow: -15448936 NOK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2023-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2023-12-31-no.zip#8403246 Filing: 529900RG33DF0N88RJ88-2023-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	NOK 0 Capital expenditure here includes intangible assets. Exact value Exact value: 0 NOK 2022-01-01 – 2022-12-31: 0 NOK Inspect Capital Expenditure Including Intangibles Open source Share or cite Citation for Capital Expenditure Including Intangibles · Aqua Bio Technology ASA · 2022-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Capital Expenditure Including Intangibles: 0 NOK Concept: fundies:CapitalExpenditureIncludingIntangibles Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88/explain?concept=fundies%3ACapitalExpenditureIncludingIntangibles&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=NOK&dimensions= Input fundies:CapitalExpenditureIncludingIntangibles: 0 NOK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2023-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2023-12-31-no.zip#8406712 Filing: 529900RG33DF0N88RJ88-2023-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−NOK 15.45 million Capital expenditure here includes intangible assets. Calculation and evidence -15448936 − 0 NOK Exact free cash flow: -15448936 NOK 2022-01-01 – 2022-12-31: -15448936 NOK · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 0 NOK · Inspect Capital Expenditure Including Intangibles · Source Share or cite Citation for Free cash flow · Aqua Bio Technology ASA · 2022-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Free cash flow: -15448936 NOK Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15448936 NOK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2023-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2023-12-31-no.zip#8403246 Filing: 529900RG33DF0N88RJ88-2023-12-31-ESEF-NO-0 Input fundies:CapitalExpenditureIncludingIntangibles: 0 NOK (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2023-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2023-12-31-no.zip#8406712 Filing: 529900RG33DF0N88RJ88-2023-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	Unavailable Not reported for this period.	−NOK 19.27 million Exact value Exact value: -19274417 NOK 2023-01-01 – 2023-12-31: -19274417 NOK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aqua Bio Technology ASA · 2023-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Operating Cash Flow: -19274417 NOK Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=NOK&dimensions= Input fundies:OperatingCashFlow: -19274417 NOK (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2024-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2024-12-31-0-no.zip#38210547 Filing: 529900RG33DF0N88RJ88-2024-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	NOK 68,200 Capital expenditure here includes intangible assets. Exact value Exact value: 68200 NOK 2023-01-01 – 2023-12-31: 68200 NOK Inspect Capital Expenditure Including Intangibles Open source Share or cite Citation for Capital Expenditure Including Intangibles · Aqua Bio Technology ASA · 2023-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Capital Expenditure Including Intangibles: 68200 NOK Concept: fundies:CapitalExpenditureIncludingIntangibles Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88/explain?concept=fundies%3ACapitalExpenditureIncludingIntangibles&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=NOK&dimensions= Input fundies:CapitalExpenditureIncludingIntangibles: 68200 NOK (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2024-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2024-12-31-0-no.zip#38214765 Filing: 529900RG33DF0N88RJ88-2024-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−NOK 19.34 million Capital expenditure here includes intangible assets. Calculation and evidence -19274417 − 68200 NOK Exact free cash flow: -19342617 NOK 2023-01-01 – 2023-12-31: -19274417 NOK · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 68200 NOK · Inspect Capital Expenditure Including Intangibles · Source Share or cite Citation for Free cash flow · Aqua Bio Technology ASA · 2023-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Free cash flow: -19342617 NOK Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19274417 NOK (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2024-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2024-12-31-0-no.zip#38210547 Filing: 529900RG33DF0N88RJ88-2024-12-31-ESEF-NO-0 Input fundies:CapitalExpenditureIncludingIntangibles: 68200 NOK (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2024-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2024-12-31-0-no.zip#38214765 Filing: 529900RG33DF0N88RJ88-2024-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	Unavailable Not reported for this period.	−NOK 56.21 million Exact value Exact value: -56205695 NOK 2024-01-01 – 2024-12-31: -56205695 NOK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aqua Bio Technology ASA · 2024-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Operating Cash Flow: -56205695 NOK Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=NOK&dimensions= Input fundies:OperatingCashFlow: -56205695 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2025-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2025-12-31.zip#1913444 Filing: 529900RG33DF0N88RJ88-2025-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	NOK 1.07 million Capital expenditure here includes intangible assets. Exact value Exact value: 1065676 NOK 2024-01-01 – 2024-12-31: 1065676 NOK Inspect Capital Expenditure Including Intangibles Open source Share or cite Citation for Capital Expenditure Including Intangibles · Aqua Bio Technology ASA · 2024-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Capital Expenditure Including Intangibles: 1065676 NOK Concept: fundies:CapitalExpenditureIncludingIntangibles Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88/explain?concept=fundies%3ACapitalExpenditureIncludingIntangibles&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=NOK&dimensions= Input fundies:CapitalExpenditureIncludingIntangibles: 1065676 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2025-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2025-12-31.zip#1922175 Filing: 529900RG33DF0N88RJ88-2025-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−NOK 57.27 million Capital expenditure here includes intangible assets. Calculation and evidence -56205695 − 1065676 NOK Exact free cash flow: -57271371 NOK 2024-01-01 – 2024-12-31: -56205695 NOK · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 1065676 NOK · Inspect Capital Expenditure Including Intangibles · Source Share or cite Citation for Free cash flow · Aqua Bio Technology ASA · 2024-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Free cash flow: -57271371 NOK Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -56205695 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2025-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2025-12-31.zip#1913444 Filing: 529900RG33DF0N88RJ88-2025-12-31-ESEF-NO-0 Input fundies:CapitalExpenditureIncludingIntangibles: 1065676 NOK (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2025-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2025-12-31.zip#1922175 Filing: 529900RG33DF0N88RJ88-2025-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	Unavailable Not reported for this period.	−NOK 8.15 million Exact value Exact value: -8152556 NOK 2025-01-01 – 2025-12-31: -8152556 NOK Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Aqua Bio Technology ASA · 2025-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Operating Cash Flow: -8152556 NOK Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=NOK&dimensions= Input fundies:OperatingCashFlow: -8152556 NOK (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2025-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2025-12-31.zip#1912911 Filing: 529900RG33DF0N88RJ88-2025-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	NOK 0 Capital expenditure here includes intangible assets. Exact value Exact value: 0 NOK 2025-01-01 – 2025-12-31: 0 NOK Inspect Capital Expenditure Including Intangibles Open source Share or cite Citation for Capital Expenditure Including Intangibles · Aqua Bio Technology ASA · 2025-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Capital Expenditure Including Intangibles: 0 NOK Concept: fundies:CapitalExpenditureIncludingIntangibles Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88/explain?concept=fundies%3ACapitalExpenditureIncludingIntangibles&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=NOK&dimensions= Input fundies:CapitalExpenditureIncludingIntangibles: 0 NOK (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2025-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2025-12-31.zip#1921638 Filing: 529900RG33DF0N88RJ88-2025-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−NOK 8.15 million Capital expenditure here includes intangible assets. Calculation and evidence -8152556 − 0 NOK Exact free cash flow: -8152556 NOK 2025-01-01 – 2025-12-31: -8152556 NOK · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 0 NOK · Inspect Capital Expenditure Including Intangibles · Source Share or cite Citation for Free cash flow · Aqua Bio Technology ASA · 2025-12-31 Aqua Bio Technology ASA (esef:529900RG33DF0N88RJ88) Free cash flow: -8152556 NOK Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-08T14:37:04Z Snapshot: d6fa81536eac3cea1a0e13fec3d3cb44fc3ca0047a659c76fd61688686dfeb04 Dimensions: Consolidated View: https://fundies.io/companies/esef/529900RG33DF0N88RJ88?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8152556 NOK (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2025-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2025-12-31.zip#1912911 Filing: 529900RG33DF0N88RJ88-2025-12-31-ESEF-NO-0 Input fundies:CapitalExpenditureIncludingIntangibles: 0 NOK (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/529900RG33DF0N88RJ88/2025-12-31/ESEF/NO/0/529900RG33DF0N88RJ88-2025-12-31.zip#1921638 Filing: 529900RG33DF0N88RJ88-2025-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

5 filings · 350 latest values · 350 originally reported values

Dataset published 2026-11-08. Source filing dates and reporting periods are shown separately.

Identifiers: 529900RG33DF0N88RJ88, esef:529900RG33DF0N88RJ88

Aqua Bio Technology ASA

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Operating cash flow

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation